British Bio-tech sets up US subsidiary
Thursday 02 December 1993
James Noble, finance director, said the development was a sign of the progress made in British Bio-tech's testing programme. 'There's no possibility of a drug getting recognised in the States without doing US clinical trials,' he said.
The new US company will operate from Annapolis in Maryland, a short drive from the FDA's Washington offices. It will also be close to other important medical centres, including the National Institute of Health and the National Cancer Institute.
The US operation will be headed by Peter McCann, who joins British Bio-tech after 20 years in the pharmaceutical industry with Marion Merrell Dow in the US and Europe.
Recent animal tests on virus- like particles have encouraged British Bio-tech to believe its Aids treatment, p24-VLP, can induce the response needed to combat viral infections.
Testing of the company's ovarian cancer product, Batimastat, has shown it to be well tolerated. Tests also suggest it could be used against a much wider range of cancers.
British Bio-tech's latest results show a second-quarter loss increased from pounds 1.8m to pounds 4.6m, which the company said was in line with its expectations. This means the loss in the six months to 31 October is up from pounds 4.7m to pounds 8.8m.
Analysts expect the company to lose about pounds 20m this year, as its drugs enter more costly testing in the later stages. British Bio-tech still had cash of pounds 39.3m at the end of the half.
The group incurred a pounds 142,000 loss on the July sale of its manufacturing business to Techne Corporation. This has left it with negligible turnover.
Gillian Anderson lays into gender disparity in Hollywood
- 1 Snoop Dogg and Jared Leto buy a stake in Reddit as A-list invests $50m
- 2 Prince held a Facebook Q&A and this is the only question he answered...
- 3 'F*ck it, I quit': KTVA reporter Charlo Greene quits live on air in spectacular fashion
- 4 35,000 walrus gather ashore on north-west Alaska beach 'for a rest'
- 5 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
Snoop Dogg and Jared Leto buy a stake in Reddit as A-list invests $50m
Prince held a Facebook Q&A and this is the only question he answered...
Kim Kardashian 'nude photos' leaked on 4chan weeks after Jennifer Lawrence scandal
Brad Pitt, on the moment he completely lost his temper with Clint Eastwood's son
Jennifer Lawrence nude photos leak: More celebrities allegedly targeted as third wave of hacked images released
Exclusive: 'Putin's Russia has been my biggest regret,' says Nato's outgoing Secretary General
The Osborne Ultimatum: Chancellor’s benefits freeze bombshell will affect ten million households
There’s no excuse for Dave Lee Travis’s behaviour, but we need to keep a sense of proportion
Mark Reckless becomes second Tory MP to defect to Ukip in a month
Should gay sex be illegal? 16% of Britons think so
Benefits 'smart cards' plan revealed by Iain Duncan Smith to stop claimants spending welfare money on alcohol
- < Previous
- Next >
iJobs Money & Business
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...
£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...
Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...